Open the mobile version, with barcode scanning
Class II Ongoing

Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 6…

Why: CGMP Deviations

Company
Baxter Healthcare Corporation
Deerfield, IL, United States
Reported
Sep 9, 2026
Recall started
Aug 6, 2026
Where sold
US Nationwide; Puerto Rico; and Chile.
Amount
N/A
Full product description
Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.
Lots / codes affected
Lot # NC194068, Exp Date: 10/29/2027.

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.